291 related articles for article (PubMed ID: 17521792)
1. Immunohistochemical and immunoblot analysis of Dopamine and cyclic AMP-regulated phosphoprotein, relative molecular mass 32,000 (DARPP-32) in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1177-81. PubMed ID: 17521792
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical and immunoblot analysis of gamma-aminobutyric acid B receptor in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Asada T
Neurosci Lett; 2005 Aug; 383(3):272-7. PubMed ID: 15955420
[TBL] [Abstract][Full Text] [Related]
3. [DARPP-32 in the patients with endogenous psychosis].
Ishikawa M; Mizukami K
Brain Nerve; 2007 Nov; 59(11):1257-63. PubMed ID: 18044203
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and immunoblot study of GABA(A) alpha1 and beta2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Hidaka S; Asada T
Neurosci Res; 2004 Sep; 50(1):77-84. PubMed ID: 15288501
[TBL] [Abstract][Full Text] [Related]
5. The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder.
Torres KC; Souza BR; Miranda DM; Nicolato R; Neves FS; Barros AG; Dutra WO; Gollob KJ; Correa H; Romano-Silva MA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):214-9. PubMed ID: 19059449
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression.
Behan AT; Byrne C; Dunn MJ; Cagney G; Cotter DR
Mol Psychiatry; 2009 Jun; 14(6):601-13. PubMed ID: 18268500
[TBL] [Abstract][Full Text] [Related]
7. Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder.
Thomas EA; Dean B; Scarr E; Copolov D; Sutcliffe JG
Mol Psychiatry; 2003 Feb; 8(2):167-75. PubMed ID: 12610649
[TBL] [Abstract][Full Text] [Related]
8. Differential protein expression of DARPP-32 versus Calcineurin in the prefrontal cortex and nucleus accumbens in schizophrenia and bipolar disorder.
Kunii Y; Hino M; Matsumoto J; Nagaoka A; Nawa H; Kakita A; Akatsu H; Hashizume Y; Yabe H
Sci Rep; 2019 Oct; 9(1):14877. PubMed ID: 31619735
[TBL] [Abstract][Full Text] [Related]
9. Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder.
Sakai T; Oshima A; Nozaki Y; Ida I; Haga C; Akiyama H; Nakazato Y; Mikuni M
Neuropathology; 2008 Apr; 28(2):143-50. PubMed ID: 18069969
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity of 43 kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia.
Tian SY; Wang JF; Bezchlibnyk YB; Young LT
Neurosci Lett; 2007 Jan; 411(2):123-7. PubMed ID: 17095155
[TBL] [Abstract][Full Text] [Related]
11. An association study between PPP1R1B gene and schizophrenia in the Chinese population.
Hu JX; Yu L; Shi YY; Zhao XZ; Meng JW; He G; Xu YF; Feng GY; He L
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1303-6. PubMed ID: 17618027
[TBL] [Abstract][Full Text] [Related]
12. Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia.
Kunii Y; Yabe H; Wada A; Yang Q; Nishiura K; Niwa S
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1139-43. PubMed ID: 21453742
[TBL] [Abstract][Full Text] [Related]
13. Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression.
Kunii Y; Hyde TM; Ye T; Li C; Kolachana B; Dickinson D; Weinberger DR; Kleinman JE; Lipska BK
Mol Psychiatry; 2014 Feb; 19(2):192-9. PubMed ID: 23295814
[TBL] [Abstract][Full Text] [Related]
14. Colocalization of dopamine receptor subtypes with dopamine and cAMP-regulated phosphoprotein (DARPP-32) in rat brain.
Rajput PS; Kharmate G; Somvanshi RK; Kumar U
Neurosci Res; 2009 Sep; 65(1):53-63. PubMed ID: 19465068
[TBL] [Abstract][Full Text] [Related]
15. GABAA receptor gamma subunits in the prefrontal cortex of patients with schizophrenia and bipolar disorder.
Ishikawa M; Mizukami K; Iwakiri M; Hidaka S; Asada T
Neuroreport; 2004 Aug; 15(11):1809-12. PubMed ID: 15257153
[TBL] [Abstract][Full Text] [Related]
16. Alterations in cell adhesion molecule L1 and functionally related genes in major depression: a postmortem study.
Laifenfeld D; Karry R; Klein E; Ben-Shachar D
Biol Psychiatry; 2005 Apr; 57(7):716-25. PubMed ID: 15820228
[TBL] [Abstract][Full Text] [Related]
17. Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics.
Pantazopoulos H; Stone D; Walsh J; Benes FM
Synapse; 2004 Dec; 54(3):147-55. PubMed ID: 15452863
[TBL] [Abstract][Full Text] [Related]
18. Detailed DARPP-32 expression profiles in postmortem brains from patients with schizophrenia: an immunohistochemical study.
Kunii Y; Ikemoto K; Wada A; Yang Q; Kusakabe T; Suzuki T; Niwa S
Med Mol Morphol; 2011 Dec; 44(4):190-9. PubMed ID: 22179181
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Dulay JR; Weis S
Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
[TBL] [Abstract][Full Text] [Related]
20. Alteration in estrogen receptor alpha mRNA levels in frontal cortex and hippocampus of patients with major mental illness.
Perlman WR; Tomaskovic-Crook E; Montague DM; Webster MJ; Rubinow DR; Kleinman JE; Weickert CS
Biol Psychiatry; 2005 Nov; 58(10):812-24. PubMed ID: 16112656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
